Evolutionary Mechanisms of Cancer Suggest Rational Therapeutic Approaches

The goal in personalized therapeutic approaches for cancer medicine is to identify specific mutations with prognostic and therapeutic value in order to tailor the therapy for the single patient. The most powerful obstacle for personalized medicine arises from intratumor heterogeneity and clonal evolution, which can promote drug resistance. In this scenario, new technologies, such as next-generation sequencing, have emerged as a central diagnostic tool to profile cancer (epi)genomic landscapes. Therefore, a better understanding of the biological mechanisms underlying cancer evolution is mandatory and represents the current challenge to accurately predict whether cancer will recur after chemotherapy with the aim to tailor rational therapeutic approaches.

Automated summary

The goal of personalized cancer medicine is to identify specific mutations with prognostic and therapeutic value for tailor-made therapy. However, the main obstacle lies in intratumor heterogeneity and clonal evolution, which can lead to drug resistance. New technologies like next-generation sequencing play a crucial role in profiling cancer (epi)genomic landscapes.